Citi Call 215 PGR 16.01.2025/ DE000KJ0SYD2 /
5/15/2024 7:27:37 PM | Chg.-0.290 | Bid8:01:36 PM | Ask- | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.860EUR | -13.49% | 1.850 Bid Size: 150,000 |
- Ask Size: - |
Progressive Corporat... | 215.00 USD | 1/16/2025 | Call |
GlobeNewswire
7:30 PM
Private Equity Firm, Initium Management, Launched by Tested Team of Trusted Operators
GlobeNewswire
2:40 PM
Thurgood Marshall College Fund added Denmark Technical College to its membership
GlobeNewswire
2:00 PM
Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
GlobeNewswire
2:00 PM
Sagimet Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire
1:00 PM
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
GlobeNewswire
1:00 PM
aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic ...
GlobeNewswire
12:30 PM
Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDi...
GlobeNewswire
1:33 AM
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Su...
GlobeNewswire
5/14
Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
5/14
scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
5/14
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment...
GlobeNewswire
5/13
Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...
GlobeNewswire
5/13
BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...
GlobeNewswire
5/13
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
GlobeNewswire
5/9
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...
GlobeNewswire
5/9
Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...
GlobeNewswire
5/8
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...
GlobeNewswire
5/7
MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-1...